+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Midatech Pharma PLC - logo

Midatech Pharma is a specialty pharmaceutical company that focuses on the commercialization of oncology treatment and supportive care pharmaceutical products in the United States. The company's best known products are Soltamox, Gelclair, Bionect, Ferralet 90 and Aquoral. The Group has a wide IP portfolio of 82 granted patents, 81 applications in process and 30 patent families covering a range of technologies. Formerly known as DARA BioSciences, Midatech was incorporated in 2002 and is headquartered in Raleigh, North Carolina.

Co-Promotion and Co-Marketing in Pharmaceuticals and Biotechnology 2014-2024 - Product Thumbnail Image

Co-Promotion and Co-Marketing in Pharmaceuticals and Biotechnology 2014-2024

  • Report
  • September 2024
  • 250 Pages
  • Global
From
Thermostable Vaccines and Thermostable Biologics Market by Type of Molecule, Target Indications, Type of Therapy, Key Players, and Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2035 - Product Thumbnail Image

Thermostable Vaccines and Thermostable Biologics Market by Type of Molecule, Target Indications, Type of Therapy, Key Players, and Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2035

  • Report
  • January 2022
  • 209 Pages
  • Global
From
Chemotherapy-induced Nausea and Vomiting Drugs - Global Strategic Business Report - Product Thumbnail Image

Chemotherapy-induced Nausea and Vomiting Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 183 Pages
  • Global
From
Somatostatin Analogs - Global Strategic Business Report - Product Thumbnail Image

Somatostatin Analogs - Global Strategic Business Report

  • Report
  • November 2024
  • 94 Pages
  • Global
From
Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
Psoriasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Psoriasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 875 Pages
  • Global
From
Somatostatin Analogs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Somatostatin Analogs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 180 Pages
  • Global
From
Somatostatin Analogs Global Market Report 2024 - Product Thumbnail Image

Somatostatin Analogs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 500 Pages +
  • Global
From
Somatostatin Analogs Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Somatostatin Analogs Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • January 2024
  • 150 Pages
  • Global
From
Histone Deacetylase Inhibitors Market by Class, Application - Global Forecast 2025-2030 - Product Thumbnail Image

Histone Deacetylase Inhibitors Market by Class, Application - Global Forecast 2025-2030

  • Report
  • October 2024
  • 193 Pages
  • Global
From
Xerostomia (Dry Mouth) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Xerostomia (Dry Mouth) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • December 2023
  • 344 Pages
  • Global
Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1036 Pages
  • Global
From
Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 143 Pages
  • Global
From
Gastrointestinal Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Gastrointestinal Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 250 Pages
  • Global
From
Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 295 Pages
  • Global
From
Fibroblast Activation Protein (FAP or Seprase) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Fibroblast Activation Protein (FAP or Seprase) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 138 Pages
  • Global
From
Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 51 Pages
  • Global
From
Long-Acting Drug Delivery Technologies and Services Market - Distribution by Principle, Strategy, Compatible Dosage Form, Type of Molecule Delivered, Type of Material Used, and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

Long-Acting Drug Delivery Technologies and Services Market - Distribution by Principle, Strategy, Compatible Dosage Form, Type of Molecule Delivered, Type of Material Used, and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • January 2023
  • 270 Pages
  • Global
From
Loading Indicator